TAS2R10 and cancer: Stern et al. identified TAS2R10 expression in human PDAC tissue (79% cancer samples) and PDAC-derived cell lines, and demonstrated a TAS2R10-dependent signaling pathway that regulates ABCG2, a transmembrane drug-effluent pump that helps cells develop chemoresistance [59].